Light therapy for brain health in sickle cell disease
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests whether shining a special light on the head (called transcranial photobiomodulation) can help children with sickle cell disease. It aims to improve blood flow and reduce brain damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sickle cell disease (any type)
- You are enrolled in the SCCRIP study program
- You are between 8 and 17 years old
- English is your main language
- You have not had a brain injury, stroke, or abnormal brain ultrasound
- You have not had a blood transfusion in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a digital program to help improve working memory (the ability to hold and use information in your mind) for children with sickle cell disease. If you join, you'll use a computer-based training program at home and researchers will see if it works and is easy to use.
This study uses MRI scans to understand how the brain and blood vessels are affected in children with sickle cell disease, including before and after certain treatments. It also includes healthy children for comparison and may help improve future monitoring and care.
This trial tests a new treatment called CS-206 for adolescents with severe sickle cell disease. It aims to see if this treatment can help by making stem cell transplants safer and more effective for people who have not done well with standard care.
This study uses a special light-based device and MRI to measure how blood vessels in the brain respond to changes. It may help researchers better understand blood flow in people with and without sickle cell disease.
This study measures how well blood flows through brain arteries in children with sickle cell disease using a noninvasive ultrasound test. It may help doctors better understand stroke risk and how treatments like hydroxyurea or recent care affect blood flow.
This study uses two brain scans—transcranial Doppler (TCD) and magnetic resonance angiography (MRA)—to monitor blood flow and arteries in children with sickle cell anemia. It aims to help guide future treatment and prevent strokes.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.